Sangani Hospitals Limited reported a consolidated net profit of ₹298.96 lakh for the financial year ended March 31, 2026, an increase from ₹259.27 lakh in the prior year. Revenue from operations rose significantly to ₹10695.81 lakh for FY26, compared to ₹2118.52 lakh in FY25. The company's board approved the standalone and consolidated audited financial results for the year on May 30, 2026.

The financial performance reflects the impact of strategic expansion initiatives undertaken during the year. Sangani Hospitals invested ₹18,81,11,970 to acquire a 55% equity stake in Sadbhavna Hospital and Medical Research Centre Private Limited, which became a subsidiary during the year. Consequently, the financial statements include the consolidation of this new subsidiary alongside existing operations.

Consolidated Financial Performance

The company's consolidated total revenue for FY26 stood at ₹10755.50 lakh, a substantial rise from ₹2279.18 lakh in the previous year. Total expenses increased to ₹9988.77 lakh from ₹1933.01 lakh. Profit before tax for the year was ₹766.73 lakh, while basic earnings per share (EPS) for the year improved to ₹2.17 from ₹1.88 in the previous year.

Standalone Results

On a standalone basis, Sangani Hospitals reported a net profit of ₹240.08 lakh for FY26, slightly lower than the ₹259.48 lakh recorded in the previous year. Revenue from operations for the standalone entity grew to ₹2110.56 lakh from ₹1679.90 lakh in FY25. The standalone results were audited by R G G R & Associates LLP, which issued an unmodified opinion.

The company's assets expanded significantly in FY26, with consolidated non-current investments reaching ₹1994.47 lakh compared to ₹81.88 lakh in the prior year, primarily due to the investment in the subsidiary. Cash and cash equivalents decreased to ₹121.43 lakh at the end of March 2026 from ₹1767.91 lakh a year earlier, reflecting the capital deployment for acquisitions and expansion.